Oktober 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) is goedgekeurd door de Food and Drug Administration voor volwassen en pediatrische patiënten van 12 jaar en ouder met lokaal gevorderde of gemetastaseerde gedifferentieerde thyroi.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..